Testing effectiveness (Phase 2)Active Not RecruitingNCT06588491
What this trial is testing
KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person Syndrome
Who this might be right for
Stiff-Person SyndromeSPS
Kyverna Therapeutics 25